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belief that current tools have deficiencies for assessing CVD risk in this high-risk population. We sought to
develop a 5-year CVD risk score using a wide range of known risk factors to further improve CVD risk
prediction in this population.
Methods We used clinical and demographic information on Indigenous people aged between 30 and 74 years without
a history of CVD events who participated in the Well Person’s Health Check (WPHC), a community-based
survey. Baseline assessments were conducted between 1998 and 2000, and data were linked to adminis-
trative hospitalisation and death records for identification of CVD events. We used Cox proportional hazard
models to estimate the 5-year CVD risk, and the Harrell’s c-statistic and the modified Hosmer-Lemeshow
(mH-L) x2 statistic to assess the model discrimination and calibration, respectively.
Results The study sample consisted of 1,583 individuals (48.1% male; mean age 45.0 year). The risk score consisted of
sex, age, systolic blood pressure, diabetes mellitus, waist circumference, triglycerides, and albumin creati-
nine ratio. The bias-corrected c-statistic was 0.72 and the bias-corrected mH-L x2 statistic was 12.01 (p-value,
0.212), indicating good discrimination and calibration, respectively. Using our risk score, the CVD risk of the
Indigenous Australians could be stratified to a greater degree compared to a recalibrated Framingham risk
score.
Conclusions A seven-factor risk score could satisfactorily stratify 5-year risk of CVD in an Indigenous Australian cohort.
These findings inform future research targeting CVD risk in Indigenous Australians.
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Early prevention of cardiovascular disease (CVD) is recog-
nised to be crucial for indigenous populations given their
substantially higher CVD risk compared to non-indigenous
people [1]. The excess CVD risk among Indigenous Austral-
ians is largely due to the very high prevalence of traditional
CVD risk factors such as hypertension and diabetes. In addi-
tion, other highly prevalent risk factors such as albuminuria
have also been shown to be associated with CVD in Indige-
nous Australians [2,3].
In CVD primary prevention, absolute CVD risk assessment
is an important component that has been widely used and
recommended [4,5]. This helps to ensure that higher-risk indi-
viduals are appropriately targeted for initiation of primary
prevention strategies [6]. While the annual CVD risk assess-
ment using a validated absolute risk algorithm has been rec-
ommendedfor Indigenous Australians [7], there iswidespread
belief that current tools have deficiencies in assessing CVD risk
in this high risk population [6,8,9]. Several studies have shown
that the equations derived from the Framingham study under-
estimate the CVD risk of Indigenous Australians [10,11]. One
explanation for this underestimation may be that certain CVD
risk factors for Indigenous people such as albuminuria and
waist circumference are not included in the Framingham CVD
equations [2,3,12,13]. While it is possible to recalibrate the
Framingham models to correct for this underestimation [11],
this does not account for a broader range of risk factors which
are potentially useful in further stratifying risk.
On the other hand, there are also circumstances in which it is
useful to stratify CVD risk using a restricted set of available risk
factors [14]. For example, sometimes Indigenous participants
were excluded from laboratory tests according to different rules
[15]. When information on traditional risk factors is not avail-
able, a standard approach for risk stratification is to produce a
model or risk chart based on a reduced set of factors [16].
In the present study, we aimed to develop and validate
prediction models for 5-year risk of CVD using data from an
Indigenous Australian cohort. We developed two models: a
primary model that included any relevant factors and a
reduced information model that does not contain laboratory
variables. After internally validating these models, we used
them to classify the study cohort as groups with high, mod-
erate and low CVD risks alongside classification based on the
Australian guidelines for CVD prevention [4] and the recali-
brated 2008 Framingham equation [11], and compared the
average risks in each predicted category with the observed
risks. Then, we examined the extent to which the Australian
guidelines may misclassify Indigenous Australians with and
without high 5-year CVD risk.Methods
Study Cohort
The cohort used in the present study was obtained from the
Well Person’s Health Check (WPHC) study [17] and has beendescribed in detail in the study by Hua et al. [11]. Briefly, the
WPHC was conducted between 1998 and 2000 and included
3,508 people in 26 rural and remote Indigenous communities
in North Queensland. For our analysis, we included Indige-
nous men and women aged between 30 and 74 years who
could be linked to hospitalisation and death records for
identification of the CVD events occurring after the study
entry. We excluded people with a history of CVD events. In
contrast to the study by Hua et al. [11], we did not exclude
people with missing risk factors at baseline. Instead, we used
imputations to replace the missing values with the estimates.
As a result, the study cohort consisted of 1,583 individuals
(see supplementary document - Figure S1 for a flow chart of
the cohort selection).
Outcome Events and Follow-Up Time
We used the definition of CVD from the Framingham Heart
Study for our outcome events, which included a composite of
coronary heart disease (coronary insufficiency, myocardial
infarction, and angina pectoris), cerebrovascular events
(ischaemic stroke, haemorrhagic stroke and transient ischae-
mic attack), congestive heart failure, peripheral vascular
disease, and coronary deaths [18]. These events were identi-
fied using the International Classification of Diseases and
procedure codes (versions ICD-9-CM and ICD-10-AM; for
details, see Hua et al.) [11]. The follow-up time was calculated
as the duration between baseline measurement and hospital-
isation of a CVD event, coronary death, non-coronary death
or last date of data collection (1 December 2014), whichever
came first. To maintain alignment with the CVD risk calcu-
lators recommended by the Australian guidelines for pre-
vention of CVD [4], a 5-year follow-up period was generated
for all individuals. This was done by considering an indi-
vidual as right censored if there was no recorded CVD event
within the 5-year follow-up period.
Statistical Analysis
Missing Data and Multiple Imputation
The percentage of observations with missing data ranged
from 0% to 15.8% depending on variables recorded in the
data set. We used multiple imputation [19] to replace missing
data with appropriate estimates (see detailed methods in
supplementary document - section 2).
Model Selection
We used Cox proportional hazard models to estimate the 5-
year CVD risk. Two models were developed: (i) the primary
model with variables selected from risk factors included in
the Framingham CVD models [18] as well as other factors
such as waist circumference [12] and albumin-to-creatinine
ratio (ACR) [2,3,20] which have been shown to be associated
with CVD risk in Indigenous populations; and (ii) the
reduced information model that excluded risk factors requir-
ing laboratory measurements. Initial covariates considered in
the primary model included sex, age, total cholesterol, high-
density lipoprotein (HDL) cholesterol, low-density lipopro-
tein (LDL) cholesterol, total cholesterol to HDL ratio,
376 A. Tran-Duy et al.triglycerides, systolic blood pressure (SBP), diastolic blood
pressure (DBP), current smoking, diabetes status, fasting
blood glucose, body mass index (BMI), waist circumference
and ACR (see supplementary document - section 3 for meth-
ods of risk factor measurements). Of note, the diabetes con-
dition was identified based on the patient self-reports and
confirmed by the primary care medical records. In the
reduced information model, only sex, age, SBP, DBP, current
smoking, diabetes status, BMI and waist circumference were
considered. To select the optimal set of predictors, we per-
formed both stepwise and manual procedures, and included
variables with a p-value smaller than 0.15 in the final models
(see supplementary document - section 4 for detailed meth-
ods). We used the scaled Schoenfeld residuals [21] to test the
proportional hazard assumption.
Risk Equation Development and Performance
Assessment
The equation for 5-year CVD risk based on the Cox propor-
tional hazard model takes the following form [22]:
p ¼ 1  Sð5Þ
exp
Pn
i¼1
b^iðxixiÞ
 
where p is the 5-year CVD risk, Sð5Þ is the survival rate at 5
years of a person with mean values of risk factors, b^i is the
estimated coefficient for the i-th risk factor, and xi and xi are
the actual and mean values, respectively, of the i-th risk
factor. We estimated S 5ð Þ and b^i and their 95% CIs by fitting
the final model to each of the imputed data sets and com-
bined the estimates using Rubin’s rule (see supplementary
document - section 5 for detailed methods).
We used the Harrell’s c-statistic [23] to evaluate the model
discrimination, i.e. the model’s ability to separate persons
with events from those without events. The c-statistic is
defined as the proportion of all possible pairs of persons,
at least one of whom has an event, in which the predicted
survival time is larger for the person who lived longer. A c
index of 0.7 or larger indicates good discrimination.
To quantify the model calibration, i.e. the agreement
between the observed and predicted risks, we used the
modified Hosmer-Lemeshow (mH-L) x2 statistic proposed
by D’Agostino and Nam for survival models [24]. The par-
ticipants were divided into deciles based on their predicted
CVD risks, and the Kaplan-Meier estimate for failure within
each decile was compared with the mean predicted risk in the
same decile. A mH-L x2 statistic larger than 20 indicates a
poor calibration [25].
To internally validate the models, we calculated the appar-
ent c and mH-L x2 statistics and corrected these for the
optimism that might arise from overfitting using the algo-
rithm developed by Harrell [23] (see supplementary docu-
ment - section 6 for detailed methods). The corrected c and
mH-L x2 statistics were shown to represent nearly unbiased
assessment of the model performance [23].
Risk Classification
We classified 1,583 individuals as either a high (>15%),
moderate (10–15%) or low 5-year CVD risk (<10%) usingthe algorithm provided by the Australian guidelines for CVD
prevention [4], the recalibrated 2008 Framingham equation
[11] and the new primary and reduced information equa-
tions, then computed mean risks and their 95% CIs within
each category using Rubin’s rule [19,26]. We used the
Kaplan-Meier estimator to compute 5-year CVD risks of
people within the same category in different imputed data
sets and combined them to estimate the observed risks. The
Australian guidelines automatically classify people with one
or more of the following conditions as high-risk people:
diabetes and age >60 years, diabetes with microalbuminuria,
moderate or severe chronic kidney disease, a history of
familial hypercholesterolaemia, a SBP  180 mmHg, serum
total cholesterol >7.5 mmol/L, or age >74. For people not
automatically classified as high risk, the 1991 Framingham
equation [27] is recommended by the Australian guidelines
for calculating the absolute risks, which are used to classify
these people into high (>15%), moderate (10–15%) and low
(<10%) risks. Therefore, people classified as high risk by the
guidelines may have or not have any of the above-mentioned
conditions. We used the same cut-off points for risk catego-
ries as those in the guidelines to classify people using our
new equations. Because the Australian guidelines do not
recommend any equation for the calculation of the actual
risk of those automatically classified as high risk, we used the
1991 Framingham equation [27] to examine their absolute
risks in reference to the observed risks and the risks predicted
by our new models and the recalibrated 2008 Framingham
model.
To examine the potential misclassification of 5-year CVD
risk using the Australian guidelines, we calculated the pro-
portions of people classified as high risk and medium-low
risk by the Australian guidelines, and within each of these
groups determined the proportions of people with a con-
trasting risk category based on our new models.Results
Of 1,583 people, 142 developed CVD within 5 years after the
first screening. We found that sex, age, SBP, waist circumfer-
ence, diabetes status, triglycerides and ACR ratio were asso-
ciated with 5-year CVD risk. Table 1 provides summary
statistics of these risk factors and the 5-year survival rate
of an average person. Current smoking and cholesterol-
related variables did not significantly contribute to the pre-
diction (p-values >0.5; see supplementary document - sec-
tion 7 for coefficients of all variables included in the full
model). Table 2 shows the regression coefficients and hazard
ratios (HRs) for CVD events associated with the risk factors in
the primary and reduced information models. The propor-
tional hazard assumption was satisfied in fitting the models
to any of the imputed data sets.
Table 3 provides performance indices of our new models
and the recalibrated 2008 Framingham model [11]. The bias-
corrected c-statistics of the primary and reduced information
models were 0.722 and 0.719, respectively, indicating good
Table 1 Baseline risk factors and 5-year survival rate of
the study cohort (N = 1,583).
Risk factor Value*
Men, % (SE)y,z 48.1 (1.3)
Age, mean (SE)y,z 45.0 (0.3)
Systolic BP, mean (SE), mmHgy,z 134.5 (0.5)
Diastolic BP, mean (SE), mmHg 75.6 (0.3)
Current smoking, % (SE) 53.4 (1.2)
BMI, mean (SE), kg/m2 28.8 (0.18)
Waist circumference, mean (SE), cmy,z 99.2 (0.4)
Diabetes, % (SE)y,z 23.2 (1.1)
Fasting blood glucose, mean (SE), mg/dL 114.4 (1.4)
Total cholesterol, mean (SE), mg/dL 198.9 (1.0)
HDL cholesterol, mean (SE), mg/dL 44.5 (0.3)
LDL cholesterol, mean (SE), mg/dL 121.2 (0.9)
Total cholesterol:HDL ratio 4.7 (0.04)
Triglycerides, mean (SE), mg/dLy 179.8 (3.7)
ACR, mean (SE) y 19.2 (1.6)
Underlying 5-year survival rate§
Primary equation 0.9298
Reduced information equation 0.9344
Abbreviations: ACR, Albumin creatinine ratio; BMI, body mass index; BP,
blood pressure; HDL, high-density lipoprotein; LDL, low-density lipopro-
tein; SE, standard deviation of the mean.
*Pooled values using Rubin’s rule [19] from estimates for 20 imputed data
sets.
yRisk factors in the primary model.
zRisk factors in the reduced information model.
§Estimated using the fitted Cox proportional hazard models for a person
with mean risk factors.
Table 2 Estimated coefficients and hazard ratios from Cox pr
Variable Primary model 
Coefficient (p-value) Haz
[95% CI] [95%
Men
0.272 (0.074) 1.32
[0.029, 0.573] [0.9
Age, years
0.050 (<0.001) 1.05
[0.038, 0.063] [1.0
Systolic BP, mmHg
0.010 (0.012) 1.01
[0.002, 0.018] [1.0
Waist circumference, cm
0.009 (0.110) 1.01
[-0.002, 0.020] [0.9
Diabetes*
0.268 (0.104) 1.32
[0.015, 0.592] [0.9
Triglycerides, mg/dL
0.001 (0.142) 1.00
[0.000, 0.001] [1.0
ACR
0.003 (0.001) 1.00
[0.001, 0.005] [1.0
Abbreviations: ACR, albumin creatinine ratio; BP, blood pressure; CI, confidence in
*Self-reported diabetes confirmed by the primary care medical records, used in bot
Prediction and classification of cardiovascular risk of Indigenous Australians 377discrimination. The bias-corrected mH-L x2 statistic (p-val-
ues) of the primary and reduced information models were
12.01 (0.212) and 12.49 (0.188), respectively, indicating good
calibration. Compared to the recalibrated 2008 Framingham
model [11], which had a bias-corrected c-statistic of 0.727 and
a bias-corrected mH-L x2 statistic (p-value) of 29.47 (0.0005),
our new models perform similarly in terms of discrimination,
but far better in terms of calibration. The observed and
predicted risks in deciles of the primary and reduced infor-
mation models were similar (Figure 1).
Table 4 shows mean observed and predicted absolute risks
for the whole cohort and different groups stratified by sex,
age and predicted risk levels. The predicted mean 5-year
risks for the whole cohort, women and men were 9.4%,
8.8% and 10.1%, respectively, using the primary model,
and were 9.4%, 8.6% and 10.2%, respectively, using the
reduced information model. These predicted values were
almost identical to the observed 5-years risks (9.4%, 8.7%
and 10.1% for the whole cohort, women and men,
respectively).
When the cohort was stratified into high, moderate and
low risks based on the predicted values, the 1991 Framing-
ham equation [27] slightly overestimated the mean risk of the
moderate-risk group (12.4% against 11.7%) and underesti-
mated the mean risk of the low-risk group (3.1% against
5.7%). In the high-risk group classified by the guidelines’
algorithm, the 1991 Framingham equation [27] underesti-
mated the mean risk of the whole group (13.8% against
17.1%), and overestimated the mean risk of persons who
did not have any of the conditions pre-defined in the guide-
lines (20.9% against 17.1%). The recalibrated 2008 Framing-
ham model [11] overestimated the mean risk in the high-riskoportional hazard models.
Reduced information model
ard ratio Coefficient (p-value) Hazard ratio
 CI] [95% CI] [95% CI]
8 0.261 (0.076) 1.312
25, 1.731] [0.031, 0.552] [0.927, 1.697]
2 0.048 (<0.001) 1.050
39, 1.065] [0.036, 0.061] [1.037, 1.062]
0 0.014 (<0.001) 1.014
02, 1.018] [0.006, 0.022] [1.006, 1.022]
0 0.009 (0.09) 1.010
99, 1.020] [0.001, 0.020] [0.998, 1.020]
5 0.405 (0.009) 1.517
74, 1.755] [0.101, 0.709] [1.055, 1.980]
1
–
–
00, 1.001]
3
–
–
01, 1.004]
terval.
h primary and reduced information models.
Table 3 Performance of the new models and the recalibrated 2008 Framingham model for 5-year CVD risk prediction.
New model Recalibrated 2008
Framingham model
Primary Reduced information
Discrimination
Apparent c-statistic 0.735 0.731 0.728
[95% CI] [0.698, 0.782] [0.701, 0.783] [0.681–0.776]
Optimism 0.013 0.012 0.001
Bias-corrected c-statistic 0.722 0.719 0.727*
Calibration
Apparent mH-L x2 statistic (p-value) 5.70 (0.770) 7.46 (0.589) 19.17 (0.024)*
Optimism 6.31 5.03 10.30
Biased-corrected mH-L x2 statistic (p-value) 12.01 (0.212) 12.49 (0.188) 29.47 (<0.001)
*These values are slightly different from those in the study by Hua et al. [11] because in the present study we used multiple imputation to replace missing values
with the estimates and evaluated performance of the recalibrated 2008 Framingham model on the 20 imputed data sets, while in the previous study [11] the
recalibrated 2008 Framingham model was evaluated on the cohort with complete cases.
378 A. Tran-Duy et al.group (26.4% against 19.5%), but slightly underestimated the
mean risk in the moderate- (12.3% against 13.2%) and low-
risk (4.5% against 5.1%) groups. In contrast, mean risks
predicted by the primary model were relatively close to
the observed risks in the high- (25.0% vs 25.4%), moderate-
(12.3% vs 12.6%) and low-risk (4.9% vs 4.6%) groups. Similar
mean predicted and observed risks in three risk categories
were observed using the reduced information model.
When risk was calculated separately for women and men
(see Tables S5 and S6 in the supplementary document), we
found that, in women, the CVD risk predicted by the 1991
Framingham model [27] was only one third of the observed
CVD risk in the youngest group (30–34 years old), while this
ratio was much larger in other age groups of women (0.53–
0.86) and in any age groups of men (0.6–1.1). When the
cohort was classified into major CVD risk categories, the
1991 Framingham equation [27] underestimated CVD riskFigure 1 Mean observed and predicted 5-year cardiovascular ri
model and (B) the reduced information model. The error bars rin all categories in women, while this was not the case in
men with moderate risk. In both women and men, the
agreement between the observed and predicted CVD risk
using the recalibrated 2008 Framingham model [11] and our
new models was much better compared to the 1991 Fra-
mingham model [27] in every age group and major risk
category.
Using the primary model, the reduced information
model, the recalibrated 2008 Framingham model [11] and
the guidelines for risk classification, the proportions of
cohort (i) with high risk were 17.1%, 18.3%, 22.0% and
28.4%, respectively, (ii) with moderate risk were 13.8%,
11.6%, 13.4% and 6.8%, respectively, and (iii) with low risk
were 69.1%, 70.2%, 64.7% and 64.8%, respectively (Figure 2).
Given the good calibration and the predicted mean risks
almost identical to the observed mean risks in any risk
categories of the new models, these figures suggest thatsks in deciles of the predicted risks using (A) the primary
epresent 95% confidence intervals.
Table 4 Mean 5-year cardiovascular risk estimated using Kaplan-Meier method, 1991 Framingham equation [27],
recalibrated 2008 Framingham model [11] and the new models for the whole cohort and groups classified by sex, age and
predicted risk levels.
Sample
size
Observed risk
based on
Kaplan-Meier
method, % [95% CI]y
Predicted risk, % [95% CI]y
1991 Framingham
equation [27]
Recalibrated 2008
Framingham model [11]
New model
Primary Reduced
information
Total 1583* 9.4 [7.9–10.8] 6.7 [6.4–7.1]{ 10.4 [9.8–10.9] 9.4 [8.9–9.8] 9.4 [8.9–9.8]
Sex
Women 822* 8.7 [6.7–10.7] 5.7 [5.2–6.2]{ 9.6 [8.9–10.3] 8.8 [8.1–9.4] 8.6 [8.1–9.3]
Men 761* 10.1 [7.9–12.2] 7.9 [7.3–8.4]{ 11.2 [10.4–11.9] 10.1 [9.4–10.6] 10.2 [9.5–10.8]
Age groups (years)
30–34 327* 3.2 [1.2–5.2] 1.3 [1.2–1.5]{ 2.9 [2.6–3.1] 3.3 [3.1–3.5] 2.8 [2.7–3.0]
35–44 541* 3.7 [2.1–5.3] 3.7 [3.4–4.0]{ 6.1 [5.7–6.5] 5.6 [5.4–5.9] 5.1 [4.9–5.3]
45–54 377* 13.0 [9.5–16.4] 7.9 [7.3–8.5]{ 11.8 [11.0–12.5] 9.9 [9.2–10.5] 9.3 [8.9–9.8]
55–74 338* 20.3 [15.8–24.6] 15.5 [14.5–16.5]{ 22.8 [21.4–24.3] 20.6 [19.5–21.7] 22.7 [21.623.8]
Risk categories based on the guidelines [4]
High (>15%) 450z 17.1 [11.0–23.2] 20.9 [19.6–22.2]§/
13.8 [12.8–14.8]{
20.4 [18.9–21.9] 16.5 [15.4–17.6] 16.3 [15.2–17.4]
Moderate (10–15%) 108z 11.7 [1.9–22.8] 12.4 [11.5–13.2] 17.1 [16.1–18.1] 14.1 [13.0–15.2] 15.8 [14.3–17.3]
Low (<10%) 1025z 5.7 [3.0–8.5] 3.1 [2.9–3.2] 5.3 [5.0–5.5] 5.7 [5.0–6.0] 5.7 [5.4–6.0]
Risk categories based on the recalibrated 2008 Framingham equation [11]
High (>15%) 348z 19.5 [13.5–25.5] 15.8 [14.9–16.7]§/
18.1 [17.1–19.1]{
26.4 [24.9–27.9] 20.4 [19.2–21.6] 21.4 [20.2–22.5]
Moderate (10–15%) 212z 13.7 [1.1–25.3] 8.4 [7.6–9.2] 12.3 [11.3–13.3] 11.6 [11.0–12.3] 11.8 [11.0k12.6]
Low (< 10%) 1023z 5.1 [1.4–9.3] 2.4 [2.2–2.6] 4.5 [4.2–4.8] 5.2 [4.7–5.3] 4.8 [4.6–5.0]
Risk categories based on the primary equation
High (>15%) 271z 25.4 [15.8–35.1] 14.7 [13.3–16.1]§/
18.0 [17.1-19.2]{
26.6 [25.0–28.2] 25.0 [23.1–25.7] 25.9 [24.7–27.1]
Moderate (10–15%) 218z 12.6 [6.6–19.9] 10.3 [9.7–10.9] 14.9 [14.1–15.8] 12.3 [12.1–12.5] 12.5 [12.1–12.8]
Low (<10%) 1094z 4.6 [2.3–7.0] 3.2 [3.0–3.4] 5.4 [5.2–5.6] 4.9 [4.9–5.1] 4.7 [4.5–4.8]
Risk categories based on the reduced information equation
High (>15%) 289z 25.2 [14.9–32.9] 13.5 [12.3–14.7]§/
17.0 [16.4–18.5]{
25.7 [24.1–27.2] 23.4 [22.1–24.6] 25.6 [24.5–26.7]
Moderate (10–15%) 183z 12.9 [5.2–20.6] 10.4 [9.7–11.1] 15.0 [14.0–15.9] 12.3 [11.8–12.8] 12.3 [12.1k12.5]
Low (<10%) 1111z 5.0 [3.0–7.1] 3.3 [3.1–3.5] 5.6 [5.4–5.9] 5.2 [5.0–5.4] 4.7 [4.5–4.8]
*Number of persons in each of 20 imputed data sets.
yPooled values using Rubin’s rule [19] from estimates for 20 imputed data sets.
zAverage number of persons across imputed data sets.
§Estimated for persons not automatically classified as those with high CVD risk by the guidelines [4], i.e. persons do not have any of the following conditions:
(1) Diabetes and age>60 years, (2) Diabetes with albumin creatinine ratio >2.5 mg/mmol for males or >3.5 mg/mmol for females, (3) moderate or severe chronic
kidney disease, (4) a previous diagnosis of familial hypercholesterolaemia, (5) Systolic blood pressure (BP)180 mmHg or diastolic BP > 110 mmHg, and (6) total
cholesterol >7.5 mmol/L.
{Estimated for all people including persons automatically classified as those with a high cardiovascular risk by the guidelines. See criteria in the previous note.
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high risk, underestimate the proportion of people with
moderate and low risk, and potentially misclassify a small
proportion of people with actual high, moderate or low risk.
The agreement between the guidelines and the new models
in classification of proportions with different risk categorieswas higher in the low-risk category than in the moderate-
and high-risk categories.
Using our new models as a standard tool for identification
of a person with a high 5-year CVD risk, we found potential
misclassification of the high risk and moderate-low risk
people by the Australian guidelines (Figure 3). Sixteen
Figure 2 Percentage of cohort with high (>15%), mod-
erate (10–15%) and low 5-year cardiovascular risk
(<10%) classified by the new models, the recalibrated
2008 Framingham model and the guidelines.
380 A. Tran-Duy et al.per cent (16%) of the population were false positives, i.e. the
individuals classified as high risk by the guidelines but as
moderate-low risk by either the primary or reduced infor-
mation model. Four per cent (4%) or 6% of the population
were false negatives on the basis of the primary or reduced
information model, respectively, i.e. the individuals classi-
fied as moderate-low risk by the guidelines but as high risk
by the primary or reduced information model. The esti-
mated sensitivity and specificity of guidelines were 74%
and 81%, respectively, based on the primary model, and
were 67% and 80%, respectively, based on the reduced
information model.Figure 3 Potential misclassification of the high risk and modera
CVD based on the (A) primary model and (B) reduced informatio
proportions of people classified as high risk (>15%) and moderat
the upper part represents the proportion of people that are misclaDiscussion
In this study, we developed the first 5-year CVD risk predic-
tion models based on Indigenous Australian data. Both the
primary model and the reduced information model per-
formed well, and had a far better calibration (mH-L x2
statistic) than the recalibrated 2008 Framingham model
[11]. This was expected as in the recalibrated model only
the baseline survival rate and means of risk factors were
derived from the Indigenous data, while the predictors
and their coefficients were obtained from the Framingham
equation [18]. As the reduced information model performed
similarly to the primary model, it provides a convenient tool
for a quick assessment of 5-year CVD risk where no labora-
tory variables are needed. Using multiple imputation com-
bined with bootstrapping, we confirmed the findings in the
study by Hua et al. [11] that the 1991 Framingham model [27]
underestimated mean 5-year risk of the Indigenous people,
and the recalibrated 2008 Framingham model [11] corrected
the under prediction of the original model. We also showed
that the 1991 Framingham equation [27] underestimated the
CVD risk more severely in younger women (aged 30–34
years) compared to older women and to men. Despite this,
the observed CVD risk in this age group is low (mean, 3.2;
95% CI, 1.2–5.2) and, therefore, this underestimation would
not have impacted the cardiovascular health of younger
women more strongly compared to older women and men.
In terms of discrimination, the primary model and the
reduced information model performed similarly to the reca-
librated 2008 Framingham model [11]. This might be because
the c-statistic is not always sensitive to model fit [28,29].
Another explanation could be that a number of risk factorste-low risk by the Australian guidelines for prevention of
n model for 5-year CVD risk prediction. The bars represent
e-low risk classified by the guidelines, within each of which
ssified on the basis of the classification by the new models.
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[30], depression [31] and history of acute rheumatic fever
[32,33] (which is still common in many Australian Indige-
nous communities [34]) were not collected and therefore
could not be controlled for in our analysis. Our data set also
did not contain information on socioeconomic deprivation, a
risk factor for CVD mortality in an Australian cohort [35].
Therefore, socioeconomic deprivation might be a potential
risk factor for CVD including both fatal and non-fatal car-
diovascular events as defined in our study. It is important to
note that the distributions of risk factors in our study sample
are different from those in the Framingham cohort [18]. For
example, participants in our study sample have a lower mean
total cholesterol (198.9 vs 213.9 mg/dL), but higher mean SBP
(134.5 vs 127.6 mmHg) and substantially higher mean rates of
smoking (53.4% vs 34.7%) and diabetes (23.2% vs 5.0%)
compared to those in the Framingham study [18]. Our mod-
els include several factors such as triglycerides and ACR that
are not included in the Framingham risk equations [18,27].
The results from our analysis confirmed previous findings
that ACR is an important CVD risk factor in Indigenous
populations [2,3]. Two studies of Indigenous Australians
showed that microalbuminuria (ACR between 3 and
30 mg/mmol) and macroalbuminuria (ACR  30 mg/mmol)
increased the risk of coronary heart disease by two to three
times compared to normal albuminuria, after adjusting for
other CVD risk factors [3,20]. We did not categorise ACR
because this reduced the model calibration.
The outcomes from our model fitting showed that, in the
presence of waist circumference, BMI was not significantly
associated with CVD risk. This is in line with the results from
the study by Wang and Hoy [12], which found that waist
circumference was a better predictor for CVD risk than BMI
in Indigenous Australians. This may be explained by the fact
that Indigenous Australians have a greater amount of
abdominal fat compared to the European Australians and
the use of BMI for weight status classification has been found
to be inappropriate in Indigenous populations [36,37].
Surprisingly, smoking was not a significant predictor of 5-
year CVD risk in our study. An explanation for this might be
that smoking was masked by SBP and triglycerides, as smok-
ing was strongly correlated with the latter. In the study by
Luke et al. [38], smoking was also found to be significantly
associated with dyslipidaemia and SBP. Although smoking
did not significantly contribute to the prediction of 5-year
CVD risk, we found it significant when fitting a model
without the constraint on the 5-year follow-up time. Hence,
the fact the smoking is not included in our models for 5-year
CVD risk prediction does not mean that reducing smoking is
not an important component of the CVD prevention strategy.
The agreement between the Australian guidelines’ algo-
rithm [4] and our new models in risk classification were only
moderate. The false positives represented the largest dis-
agreement, which can lead to unnecessary treatment and
increased health care costs. The consequences of false neg-
atives are potentially severe with individuals who would
otherwise be medicated not receiving treatment to reduceCVD risk. Although the proportion of people with false
negatives was relatively small (about 4–6% of the popula-
tion), this is roughly equivalent to a large number of 31,000–
47,000 Indigenous people with high CVD risk but could
potentially be untreated, assuming that the distributions of
the risk factors in the WPHC was similar to those in the
Indigenous Australian population [39].
As our models were able to better classify the CVD risk of
Indigenous people compared to the algorithm recommended
by the Australian guidelines [4], they should be considered as
a contemporarily evidence-based tool for CVD risk assess-
ment in remote Indigenous Australians. Since CVD is the
leading cause of death in Indigenous Australians [40], trans-
lation of our findings to clinical practice is an important step
towards addressing the target set by the Commonwealth of
Australia, that is to close the gap in life expectancy between
Indigenous and non-Indigenous Australians within a gener-
ation [41,42]. Detailing strategies for this translation is
beyond the scope of the present study, but it is worth noting
that developing a tool for risk assessment that is readily
available and acceptable to health professionals and Indige-
nous communities is crucial. Communication of this tool and
our findings with physicians can be done in collaboration
with the Heart Foundation and other relevant organisations
via the internet, scientific meetings and media.
Strengths and Limitations
In the present study, we used a relatively large community-
based cohort and high-quality data for model development,
multiple imputation to deal with missing data, and rigorous
methods to select the predictors and assess the model per-
formance. However, our study has some limitations. The
cohort used for model development might not represent
the Indigenous population in North Queensland because
the participants in the screening program were volunteers.
Because our models were developed for remote Indigenous
people and have not been tested in other populations, their
generalisability is currently inconclusive. However, they pro-
vide an additional evidence-based tool for risk assessment
that can be used alongside existing risk scores such as the
recalibrated Framingham model [11]. As data on treatment
for hypertension were not ascertained in our study, our
models did not include treatment as a covariate, which is
aligned with the 1991 Framingham equation [27]. However,
we note that the 2008 Framingham equation [18] accounted
for the effect of anti-hypertensive treatment and therefore it is
important to explore this treatment effect in future studies for
risk stratification in Indigenous populations. Other potential
risk factors such as family history of CVD [30], socioeconomic
deprivation [35] and rheumatic heart disease [32,33] were not
collected, and thus additional relevant predictors might be
missed to be included in the models. Our equations were
designed as a risk prediction tool and thus they may not
represent all key risk factors associated with the aetiology of
CVD. An example of this is the inclusion of triglycerides as
the sole lipid fraction in our primary model while there is a
well-established strong correlation between CVD and other
382 A. Tran-Duy et al.lipid fractions such as total and HDL cholesterol [30]. In this
respect the role of triglycerides in our equation represents
both the direct impact as well as the indirect impact on CVD
via its correlation with other lipid fractions in Indigenous
Australians [43,44]. Although we rigorously assess the model
performance internally, external validation of the models
using other data sources is needed and this warrants further
study in the future.Conclusions
The algorithm for classification of people as high, moderate
and low 5-year CVD risk recommended by the Australian
guidelines for prevention of CVD [4] is subject to misclassi-
fication of Indigenous people in these major risk categories,
and is not accurate in estimating mean absolute risk in each of
these categories. The prediction models we developed
improved these. The reduced information model, with good
discrimination and calibration, provides a convenient and
reasonable tool for a quick assessment of 5-year CVD risk
where no laboratory variables are required.Funding Source
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